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Regulated intramembrane proteolysis (RIP) represents an
evolutionarily conserved process linking receptor function
with transcriptional regulation. Best characterized by the
Notch signaling pathway, RIP involves regulated ectodomain
shedding followed by c-secretase-mediated release of the
C-terminal, cytosolic domain. The C-terminus in turn
translocates to the nucleus where it interacts with other
proteins to regulate expression of specific genes. Recent
studies in our laboratory have shown that megalin, a
scavenger receptor in proximal tubule, is subjected to RIP in a
manner very similar to that of Notch. We showed that
megalin in subjected to protein kinase C-regulated,
metalloprotease-mediated ectodomain shedding producing
a membrane-associated C-terminal fragment (MCTF). The
MCTF in turn forms the substrate for c-secretase. These data
implicate megalin as a central element of a Notch-like
signaling pathway linking protein reabsorption and gene
regulation in proximal tubule. The likelihood that megalin
processing plays an important role in the progression of
proteinuric kidney disease is discussed.
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Elevated urinary protein is one of the most significant
predictors of renal disease and controlling proteinuria in the
patient with proteinuric kidney disease is paramount for the
physician. Increasing evidence from both animal and cell
culture models show that chronic proteinuria not only acts as
an index of renal pathology but also that elevated protein is
toxic to the renal tubular epithelium. Although the molecular
mechanisms of this toxicity are largely unknown, experi-
mental evidence indicates that albumin can activate trans-
cription of both NF-kB-dependent and NF-kB-independent
genes leading to increased secretion of both cytokines and
chemokines by proximal tubule cells. It has been suggested
that this change in phenotype of the proximal tubule in turn
leads to the inflamed and fibrotic states seen in the
proteinuric kidney. For a recent review, see Gekle.1 Under-
standing in detail the molecular mechanisms of tubular
protein reabsorption and how this process may regulate gene
expression in the proximal tubule is an important goal for
nephrologists.
The proximal tubule reabsorbs filtered protein from the
urine largely by clathrin-dependent, receptor-mediated endo-
cytosis. It is clear from biochemical and gene knockout
studies that the scavenger receptor megalin performs a
central role in renal protein reabsorption.2 A member of the
low-density lipoprotein-receptor gene family, megalin was
first discovered and identified as the Heymann nephritis
autoantigen by Kerjaschki and Farquhar in 1982.3 Originally
called gp330, megalin was shown to be highly expressed in
the clathrin-coated pit region of the renal brush border and,
because of its subcellular location, predicted to be involved in
endocytosis. Subsequent studies have identified an impressive
list of ligands that bind megalin in vitro and include albumin,
vitamin-binding proteins, carrier proteins, lipoproteins,
hormones such as insulin, drugs and toxins, enzymes, and
others such as Ca2þ and receptor-associated protein. For an
excellent review, see Christensen and Birn.2 Although the
physiologic importance of megalin’s binding to many of the
ligands described in the literature is not known, it is generally
accepted that megalin functions as a scavenger receptor in the
proximal tubule. Recently, new data from our laboratory
showing that megalin is subjected to a process called regu-
lated intramembrane proteolysis (RIP) provide a working
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model linking megalin-dependent receptor-mediated endo-
cytosis with cell signaling events. These findings may also
help to explain at the molecular level the link between
chronic proteinuria and the pathology seen clinically in
patients with proteinuric renal diseases.
CELL SIGNALING THROUGH RIP
As part of their studies of cholesterol metabolism, Brown and
Goldstein and co-workers discovered that a receptor involved
in cholesterol metabolism, called the sterol regulatory
element binding protein, was subjected to a series of
regulated proteolytic cleavages. Specific proteolytic fragments
of sterol regulatory element binding produced during this
process were shown to be translocated to the nucleus,
resulting in transcriptional regulation of specific genes
involved in both fatty acid and cholesterol metabolism4).
RIP of sterol regulatory element binding is now known to
represent an evolutionarily conserved process that acts on
numerous receptors and link receptor-mediated endocytosis
with intracellular signaling events. Among the growing list of
receptors now known to be subjected to RIP, Notch and the
amyloid precursor protein (APP) are probably the best
studied. Notch, a 300 kDa single membrane pass receptor,
was first described in Drosophila melanogaster and shown to
be necessary for neural development in that species. It is
now clear that Notch is part of a signaling pathway that
determines cell fate in many tissues in both vertebrates and
invertebrates alike. Proteolytic processing of Notch appears
to be similar, if not identical, to processing described for the
APP. Understanding the proteolytic processing steps of APP
has become the focus of many studies because increasing
evidence indicates that anomalies in APP processing by a, b,
and g secretases result in the production of pathogenic
fragments, known as the amyloid b peptides, which have
been linked to the onset and progression of Alzheimer’s
disease. An overview of the relevant features of the RIP of
Notch is shown in Figure 1 and is summarized below.
The initial step (2) in RIP is ectodomain shedding.5 The
shedding activity is protein kinase C-regulated and frequently
occurs as multiple steps involving distinct proteases for each
step. The role of ligand binding (1) for RIP seems to be quite
variable. In some instances, for example in the case of Notch,
ligand binding is required for ectodomain shedding to occur.
However, for other receptors, including APP, the role of
ligand binding is unclear and ectodomain shedding along
with all subsequent processing steps seem to be largely
constituitive. Ectodomain shedding is carried out by one or
more members of the metalloprotease-disintegrin family of
proteases, also called ADAMs (a disintegrin and metallopro-
tease domain). ADAM17, also called tumor necrosis factor-a-
converting enzyme and ADAM10 (Kuzbanian) appear to be
important enzymes for ectodomain shedding of both Notch
and APP.6
Ectodomain shedding of Notch yields characteristic
membrane-associated C-terminal fragments (referred to as
NCTF in Figure 1). The NCTF in turn forms the substrate for
g-secretase activity (3) acting at a site within the transmem-
brane domain. The g-secretase cleavage site has been
identified by N-terminal sequencing for both Notch and
APP, and shown to occur immediately before a valine residue
located 3–4 amino acids from the putative membrane/
cytosolic boundary.7 g-Secretase activity is mediated by a
protein complex that includes the presenilins (1 and 2),
which appear to mediate the proteolytic activity, as well as
‘accessory’ proteins pen-2, aph-1, and nicastrin whose
functions are largely unknown. New studies suggest that
additional posttranslational steps may be required for the
g-secretase cleavage to occur. Gupta-Rossi and co-workers
have shown that monoubiquitination and endocytosis of the
NCTF are both required prior to cleavage by g-secretase.8
Once cleaved, the soluble C-terminal domain is trafficked to
the nucleus (4), where it interacts with transcription factors
and regulates expression of specific genes. The intracellular
domain of Notch interacts with the CSL (CSL stands for
CBF1, Su(H), Lag-1) family of DNA-binding proteins (5).
In 2002, members of Joachim Herz’ laboratory published
a study showing that a protein closely related to megalin
called low density lipoprotein receptor related protein is also
subjected to RIP.9 In a subsequent review discussing the
relationship between endocytosis and cellular signaling of
lipoprotein receptors, May and Herz suggested that megalin
may also be subjected to RIP and might be involved in
regulating genes of the vitamin D metabolic pathway in the
proximal tubule.10 This idea was founded largely on work by
Willnow and co-workers, who had earlier shown megalin is
required for the uptake and activation of 25-(OH) vitamin
D3 by the proximal tubule.
11 Willnow’s group also identified,
using the yeast-two-hybrid technique, a protein called MegBP
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Figure 1 | The Notch signaling pathway. Signaling (transcriptional
regulation) through the Notch pathway occurs in several distinct
steps. Ligand binding (step 1) initiates ectodomain shedding (step 2)
by one or more metalloproteases producing a membrane-associated
C-terminal fragment (NCTF for Notch C-terminal Fragment). The NCTF
in turn becomes the substrate for g-secretase (3) resulting in RIP and
releasing the Notch intracellular domain into the cytosol. The NICD is
translocated to the nucleus (4), where it interacts with CSL (CBF1,
Su(H), Lag-1) transcription factors (5) resulting in transcriptional
regulation of target genes (6).
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(for megalin-binding protein), which interacted with both
the C-terminal cytosolic domain of megalin and with
SKI-interacting protein, a transcriptional regulator and
co-activator of the vitamin D receptor.12
RIP OF MEGALIN IN PROXIMAL TUBULE CELLS
With this in mind we began studies designed to look for RIP
of megalin in kidney. Interestingly, we noticed conservation
of the predicted critical valine residue (the g-secretase
cleavage site) in the transmembrane domain of megalin.
Initially, we sought to determine if significant levels of
g-secretase activity, as well as presenilin protein, are expressed
in renal brush border. Figure 2 shows that immunocyto-
chemical studies were able to localize presenilin-1 to the
brush border as well as to the endocytic apparatus of
proximal tubule cells. The localization of presenilin to the
renal brush border was supported biochemically by the
findings that high levels of presenilin-1 protein and
g-secretase activity were enriched in renal brush border
membrane vesicles.13 Therefore, the subcellular location of
presenilin-1, and thus g-secretase, in proximal tubule
significantly overlaps that described for megalin.
In order to perform more detailed biochemical studies
and look for Notch-like processing of megalin, we utilized a
well-established cell line derived from opossum proximal
tubule called OKP. OKP cells express significant levels of
megalin and have been used by several laboratories to study
the interrelationship between protein absorption and gene
expression in proximal tubule. Studies from Gekle’s labora-
tory have established megalin to be the primary receptor for
receptor-mediated endocytosis of albumin in this cell line.14
More importantly, endocytosis of albumin, again presumably
by a megalin-dependent pathway, is now known to result in
the specific activation of several genes in cultured proximal
tubule cells including fractalkine (CX3CL1),15 RANTES
(regulated upon activation, normal T cell expressed and
secreted) 16 and the brush border Naþ /Hþ exchanger,
NHE3.17
Our laboratory has cloned the C-terminal region of
megalin from OKP cells and has developed both monoclonal
and polyclonal antibodies to this region of the receptor.
These reagents have been applied to studies of OKP cells and
used successfully to study the biogenesis of megalin and
especially its proteolytic processing in this cell line. We
discovered that, like Notch, APP and low density lipoprotein
receptor related protein, the ectodomain of megalin is shed
(Figure 3, (2)) in OKP cells by a protein kinase C-regulated,
metalloprotease-mediated activity.13 Ectodomain shedding
produced a 40–45 kDa membrane bound, C-terminal frag-
ment of the receptor, which we refer to as the megalin
C-terminal fragment or MCTF (Figure 3). Importantly, the
MCTF is the same size as a major C-terminal fragment of
megalin found in kidney and is similar to C-terminal
fragments produced when other receptors are similarly
subjected to ectodomain shedding. Although the exact
identity of the megalin sheddase(s) and the cleavage site are
unknown, the mechanism seems to be similar, if not
identical, to that described for other receptors subjected to
RIP. We found that ectodomain shedding of megalin had
both constituitive and ligand-dependent (1) components.
Specific megalin ligands, such as vitamin D-binding protein,
activated the shedding process. In these experiments,
the MCTF produced by ectodomain shedding formed the
substrate for g-secretase activity (3). The half-life of the
megalin intracellular domain thus formed is very short, and
we have not been able to follow its subcellular trafficking (4)
(i.e. to the nucleus). This again is consistent with data
derived from studies of other receptors. For example, the
Figure 2 | Immunolocalization of presenilin-1 in kidney. Perfusion-
fixed rat kidney was stained with a polyclonal antipresenilin-1
antibody. Note that the staining for presenilin-1 is largely restricted to
the brush border and endocytic region of proximal tubules.
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Figure 3 | Megalin as part of a ‘Notch-like’ signaling pathway in
the proximal tubule. This scheme shows known and postulated (?)
events in a proposed megalin signaling pathway. Metalloprotease
(MMP) activity, activated by ligand binding (1) and regulated by
protein kinase C, results in ectodomain shedding (2) of megalin.
Ectodomain shedding produces an MCTF. The MCTF in turn becomes
the substrate for g-secretase activity acting in the membrane and
releasing the ‘free’ C-terminal intracellular domain (megalin intracel-
lular domain) into the cytosol (3). The megalin intracellular domain
translocates (4) to the nucleus where it acts as a transcriptional
regulator. Presenilin is the active component of the g-secretase
protein complex and is specifically inhibited by Compound E.
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g-secretase product of endogenous Notch, the Notch intra-
cellular domain, is not detectable and studies that have
localized the Notch intracellular domain to the nucleus have
done so by overexpressing the Notch gene in cultured cells.
WHAT IS THE FUNCTION OF MEGALIN PROCESSING
IN PROXIMAL TUBULE?
In agreement with the prediction of May and Herz, we
conclude from these studies that key elements of a Notch-like
signaling pathway, using megalin as a novel substrate, exists
in the proximal tubule. The downstream events of this
pathway shown in Figure 3 such as targeting of the megalin
intracellular domain to the nucleus and gene regulation are
predictions based on other similar pathways such as Notch.
Our data show that RIP of megalin can be activated by
vitamin D-binding protein and are consistent with the idea
that this pathway regulates genes involved in vitamin D
metabolism in the proximal tubule. However, regulation of a
specific set of genes involved in vitamin D metabolism would
be difficult to reconcile if megalin is in fact a multiligand,
scavenger receptor. Therefore, an important question that
will need to be addressed is: ‘If the megalin signaling pathway
is activated by ligands, do all megalin ligands activate
processing equally and activate the same genes?’
The fact that megalin is expressed in the brush border of
the proximal tubule means that it is in direct contact with the
glomerular ultrafiltrate. Another intriguing role for megalin
as a signaling molecule in proximal tubule may be that it acts
as a ‘sensor’ of urinary protein filtered by the glomerulus. In
this case, megalin processing might regulate brush border
gene products involved in brush border activity, and thus
directly influence the absorptive capacity of proximal tubule
cells. The interrelationship between endocytosis and cell
signaling is a well-established process.18,19 In proximal
tubule, a model of endocytosis-regulated protein expression,
possibly at the transcriptional level, is supported by gene
knockout studies. Jentsch’s group has developed a knockout
the brush border endosomal Cl channel, ClC-5. In addition
to inhibiting receptor-mediated endocytosis in proximal
tubule, the loss of ClC-5 also inhibits megalin protein
expression.20 More dramatically, megalin knock animals
exhibit poorly developed brush borders. These animals have
severe proteinuria as might be expected from megalin loss of
function. However, the proximal tubules of these animals also
exhibit a markedly reduced endocytic pathway suggesting
that some aspect of megalin function regulates expression of
other proteins involved in endocytosis. The appearance of
coated pits, endosomes, and dense apical tubules are
generally reduced in the absence of megalin. The increased
appearance of specific proteins, for example vitamin D-
binding protein, in the urine of the megalin / animals has
been offered as evidence that megalin is a receptor for these
proteins. However, it is difficult to reconcile if the proteinuria
seen in these animals results from loss of the receptor
function of megalin or from the generalized reduction of the
endocytic pathway itself. It is tempting to speculate that the
proteinuria seen in the megalin/ animals might result
from the loss of megalin function as a signaling molecule
rather than as a receptor per se. Additional studies will be
required to understand how the receptor and signaling
functions of megalin interact and relate to one another.
What role might megalin signaling play in proteinuric
kidney disease? It is easy to imagine that a megalin-
dependent signaling pathway in proximal tubule would be
dramatically impacted during states of chronic proteinuria.
Knowledge of the downstream signaling events of this
pathway, especially with regard to the genes that might be
regulated, may have important consequences for our under-
standing of the onset and progression renal disease. The
albumin-dependent changes in gene expression seen in
cultured proximal tubule cells may be mediated directly
through megalin’s signaling function. This function could
also explain the change in phenotype of proximal tubules
during proteinuric kidney disease, and may participate in the
progressive renal damage seen in the nephrotic state.
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